Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Roila · SciRah

Researcher profile · Semantic Scholar

F. Roila

Share profile

F. Roila — researcher profile on SciRah

h-index: 56
Works: 275
Citations: 13K

Most-cited papers

Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines.
G. Curigliano, D. Cardinale, Thomas M. Suter, G. Plataniotis +6 more
2012Annals of Oncology854 citations Open access
Semantic Scholar
Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment.
A. Fabi, R. Bhargava, S. Fatigoni, M. Guglielmo +5 more
2020Annals of Oncology498 citations Open access
Semantic Scholar
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients.
F. Roila, A. Molassiotis, J. Herrstedt, M. Aapro +15 more
2016Annals of Oncology456 citations Open access
Semantic Scholar
[Cancer-related fatigue].
S. Fatigoni, G. Fumi, F. Roila
2015Recenti progressi in medicina378 citations
Semantic Scholar
The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER).
M. Aapro, A. Molassiotis, M. Dicato, I. Peláez +7 more
2012Annals of Oncology312 citations Open access
Semantic Scholar
Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study.
A. Molassiotis, M. Aapro, M. Dicato, P. Gascón +5 more
2014Journal of Pain and Symptom Management162 citations Open access
Semantic Scholar
Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain.
E. Bandieri, M. Romero, C. Ripamonti, F. Artioli +11 more
2016Journal of Clinical Oncology151 citations Open access
Semantic Scholar
2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy
J. Herrstedt, F. Roila, D. Warr, L. Celio +4 more
2016Supportive Care in Cancer123 citations
Semantic Scholar
Supportive care in cancer—a MASCC perspective
I. Olver, D. Keefe, J. Herrstedt, D. Warr +2 more
2020Supportive Care in Cancer122 citations
Semantic Scholar
Anticipatory Nausea, Risk Factors, and Its Impact on Chemotherapy-Induced Nausea and Vomiting: Results From the Pan European Emesis Registry Study.
A. Molassiotis, P. Lee, T. Burke, M. Dicato +3 more
2016Journal of Pain and Symptom Management80 citations Open access
Semantic Scholar
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin
P. Bossi, D. Cortinovis, S. Fatigoni, M. C. Rocca +14 more
2017Annals of Oncology71 citations Open access
Semantic Scholar
Aprepitant versus dexamethasone for preventing chemotherapy-induced delayed emesis in patients with breast cancer: a randomized double-blind study.
F. Roila, B. Ruggeri, E. Ballatori, A. del Favero +1 more
2014Journal of Clinical Oncology71 citations
Semantic Scholar
Cognitive impairment and chemotherapy: a brief overview.
M. Vitali, C. Ripamonti, F. Roila, C. Proto +8 more
2017Critical reviews in oncology/hematology70 citations
Semantic Scholar
Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non-small cell lung cancer.
F. Grossi, C. Genova, L. Crinò, A. Delmonte +18 more
2019European Journal of Cancer67 citations
Semantic Scholar
Proton Pump Inhibitors in cancer patients: How useful they are? A review of the most common indications for their use.
G. Numico, V. Fusco, P. Franco, F. Roila
2017Critical reviews in oncology/hematology60 citations
Semantic Scholar
Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy: a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO)
F. Roila, G. Fumi, B. Ruggeri, A. Antonuzzo +16 more
2018Supportive Care in Cancer59 citations
Semantic Scholar
2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy
F. Roila, D. Warr, P. Hesketh, R. Gralla +5 more
2016Supportive Care in Cancer59 citations
Semantic Scholar
ICH in primary or metastatic brain cancer patients with or without anticoagulant treatment: a systematic review and meta-analysis
M. Giustozzi, Giulia Proietti, C. Becattini, F. Roila +2 more
2022Blood Advances51 citations Open access
Semantic Scholar
Outcomes from salvage chemotherapy or pembrolizumab beyond progression with or without local ablative therapies for advanced non-small cell lung cancers with PD-L1 ≥50% who progress on first-line immunotherapy: real-world data from a European cohort.
G. Metro, A. Addeo, D. Signorelli, A. Gili +18 more
2019Journal of Thoracic Disease43 citations Open access
Semantic Scholar
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool
M. Mandarano, G. Bellezza, M. L. Belladonna, J. Vannucci +14 more
2020Frontiers in Immunology39 citations Open access
Semantic Scholar
2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomiting
C. Ruhlmann, Franziska Jahn, K. Jordan, K. Dennis +4 more
2016Supportive Care in Cancer37 citations Open access
Semantic Scholar
Targeting inflamed and non-inflamed melanomas: biological background and clinical challenges.
A. Indini, D. Massi, M. Pirro, F. Roila +5 more
2022Seminars in Cancer Biology36 citations Open access
Semantic Scholar
Sensitivity to Immune Checkpoint Blockade in Advanced Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations
G. Metro, S. Baglivo, G. Bellezza, M. Mandarano +19 more
2021Genes36 citations Open access
Semantic Scholar
Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab
A. Friedlaender, G. Metro, D. Signorelli, A. Gili +18 more
2020Acta oncologica36 citations Open access
Semantic Scholar
Fatigue, a major still underestimated issue
C. Ripamonti, A. Antonuzzo, P. Bossi, S. Cavalieri +2 more
2018Current Opinion in Oncology31 citations
Semantic Scholar
Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy.
G. Mountzios, A. De Toma, P. Economopoulou, A. Friedlaender +19 more
2020Clinical Lung Cancer30 citations
Semantic Scholar
Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study.
F. Roila, B. Ruggeri, E. Ballatori, S. Fatigoni +14 more
2015Annals of Oncology29 citations Open access
Semantic Scholar
A review of olanzapine as an antiemetic in chemotherapy-induced nausea and vomiting and in palliative care patients.
C. Fonte, S. Fatigoni, F. Roila
2015Critical reviews in oncology/hematology29 citations
Semantic Scholar
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients
V. Ludovini, F. Bianconi, A. Siggillino, J. Vannucci +13 more
2021Genes25 citations Open access
Semantic Scholar
Efficacy of Pembrolizumab Monotherapy in Patients With or Without Brain Metastases From Advanced Non–Small Cell Lung Cancer With a PD-L1 Expression ≥50%
G. Metro, G. Banna, D. Signorelli, A. Gili +19 more
2020Journal of immunotherapy24 citations
Semantic Scholar
Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis.
M. di Maio, C. Baratelli, P. Bironzo, F. Vignani +4 more
2018Critical reviews in oncology/hematology24 citations Open access
Semantic Scholar
Molecular Profiling and Novel Therapeutic Strategies for Mucosal Melanoma: A Comprehensive Review
A. Indini, F. Roila, F. Grossi, D. Massi +1 more
2021International Journal of Molecular Sciences23 citations Open access
Semantic Scholar
Hepatitis B in immunosuppressed cancer patients: pathogenesis, incidence and prophylaxis.
M. Mandalà, S. Fagiuoli, D. Francisci, R. Bruno +5 more
2013Critical reviews in oncology/hematology22 citations
Semantic Scholar
Renal malignant solitary fibrous tumor with single lymph node involvement: report of unusual metastasis and review of the literature
E. Mearini, G. Cochetti, F. Barillaro, S. Fatigoni +1 more
2014OncoTargets and Therapy18 citations Open access
Semantic Scholar
Vascular events with immune checkpoint inhibitors in melanoma or non-small cell lung cancer: A systematic review and meta-analysis.
M. Giustozzi, C. Becattini, F. Roila, G. Agnelli +1 more
2021Cancer Treatment Reviews17 citations
Semantic Scholar
Detection of EGFR Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp, and Digital PCR
A. Siggillino, P. Ulivi, L. Pasini, M. S. Reda +9 more
2020Diagnostics17 citations Open access
Semantic Scholar
RET Rearrangement as a Predictor of Unresponsiveness to Immunotherapy in Non-Small Cell Lung Cancer: Report of Two Cases with Review of the Literature
S. Baglivo, V. Ludovini, R. Moretti, G. Bellezza +3 more
2020Oncology and Therapy16 citations Open access
Semantic Scholar
Use of Electronic Administrative Databases to Measure Quality Indicators of Breast Cancer Care: Experience of Five Regional Oncology Networks in Italy
V. Guarneri, P. Pronzato, O. Bertetto, F. Roila +13 more
2019Journal of Oncology Practice15 citations Open access
Semantic Scholar
Upfront pembrolizumab as an effective treatment start in patients with PD-L1 ≥ 50% non-oncogene addicted non-small cell lung cancer and asymptomatic brain metastases: an exploratory analysis
G. Metro, A. Gili, D. Signorelli, A. De Toma +11 more
2021Clinical and Translational Oncology14 citations
Semantic Scholar
Supportive Care: Low Cost, High Value.
R. Popescu, F. Roila, J. Arends, G. Metro +1 more
2021American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting14 citations Open access
Semantic Scholar
Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy
F. Roila, D. Warr, P. Hesketh, R. Gralla +5 more
2016Supportive Care in Cancer14 citations Open access
Semantic Scholar
Searching for Evidence to Support the Use of Ginger in the Prevention of Chemotherapy-Induced Nausea and Vomiting
P. Bossi, D. Cortinovis, Maria Cossu Rocca, F. Roila +8 more
2016Journal of Alternative and Complementary Medicine14 citations Open access
Semantic Scholar
Prevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study
J. Foglietta, V. Ludovini, F. Bianconi, L. Pistola +9 more
2020Genes13 citations Open access
Semantic Scholar
Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting.
D. Generali, F. Montemurro, R. Bordonaro, A. Mafodda +27 more
2017The Oncologist12 citations Open access
Semantic Scholar
Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial
A. Antonuzzo, C. Ripamonti, F. Roila, A. Sbrana +19 more
2022Frontiers in Oncology11 citations Open access
Semantic Scholar
Immune checkpoint inhibitors for unresectable malignant pleural mesothelioma
G. Metro, D. Signorelli, E. Pizzutilo, L. Giannetta +7 more
2021Human Vaccines & Immunotherapeutics11 citations Open access
Semantic Scholar
Impact of Circulating and Tissue Biomarkers in Adjuvant and Neoadjuvant Therapy for High-Risk Melanoma: Ready for Prime Time?
A. Indini, F. Roila, F. Grossi, D. Massi +1 more
2021American Journal of Clinical Dermatology10 citations Open access
Semantic Scholar
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors
M. Mandalà, G. Palmieri, V. Ludovini, S. Baglivo +18 more
2023Journal of the European Academy of Dermatology and Venereology8 citations Open access
Semantic Scholar
Incidence, management, and resolution of noninfectious pneumonitis in BOLERO-2.
Y. Ito, S. Noguchi, I. Deleu, J. Baselga +16 more
20138 citations
Semantic Scholar
Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with Immunotherapy
S. Baglivo, F. Bianconi, G. Metro, A. Gili +13 more
2021Genes7 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

G. Metro×13
Invite
G. Metro — researcher profile on SciRah
S. Fatigoni×9
Invite
S. Fatigoni — researcher profile on SciRah
D. Signorelli×8
Invite
D. Signorelli — researcher profile on SciRah
A. Gili×8
Invite
A. Gili — researcher profile on SciRah

×8

Invite

V. Ludovini — researcher profile on SciRah

C. Ripamonti×7

Invite

C. Ripamonti — researcher profile on SciRah

Invite

M. Mandalà — researcher profile on SciRah

Invite

M. Aapro — researcher profile on SciRah

Invite

A. Addeo — researcher profile on SciRah

Invite

G. Bellezza — researcher profile on SciRah

Invite

S. Baglivo — researcher profile on SciRah

Invite

A. Fabi — researcher profile on SciRah